Related Experiment Videos
Prednisone-induced alterations of circulating human lymphocyte subsets.
The Journal of Laboratory and Clinical Medicine
|March 1, 1983
Summary
Prednisone, a common glucocorticoid, causes peripheral lymphopenia by reducing T cells, particularly the OKT4+ subset. This effect is dose-dependent and not due to cell death or spleen redistribution.
Area of Science:
- Immunology
- Pharmacology
Background:
- Glucocorticoids, like prednisone, are known to cause peripheral lymphopenia in humans.
- The specific T cell subsets affected by glucocorticoid administration require further elucidation.
Purpose of the Study:
- To investigate the effects of prednisone on peripheral T cell subsets (OKT4+ and OKT8+) in healthy subjects.
- To determine the dose-dependency and mechanism of prednisone-induced lymphopenia.
Main Methods:
- Four healthy subjects ingested 20 mg of prednisone.
- Peripheral blood T cell subsets (OKT11+, OKT4+, OKT8+) were quantified using monoclonal antibodies before and after prednisone administration.
- In vitro exposure of lymphocytes to methylprednisolone was performed.
- Prednisone's effect was assessed in a splenectomized subject.
Main Results:
- Prednisone administration led to a decline in circulating T cells, with a disproportionate decrease in the OKT4+ (helper-inducer) subset.
- The ratio of OKT4+ to OKT8+ cells decreased significantly post-prednisone.
- No significant lympholysis or alteration in T cell subset proportions was observed with in vitro methylprednisolone exposure.
- Prednisone-induced lymphopenia was observed in both splenectomized and non-splenectomized subjects.
- B cell counts remained unaffected.
Conclusions:
- Prednisone-induced lymphopenia primarily affects the OKT4+ T cell subset more than the OKT8+ subset.
- The mechanism is not attributed to direct lympholysis or splenic redistribution of lymphocytes.
- The findings highlight the immunomodulatory effects of prednisone on specific T cell populations.